BENZIMIDAZOLIDINONE DERIVATIVES AS MUSCARINIC AGENTS
申请人:Acadia Pharmaceuticals Inc.
公开号:EP1432420B1
公开(公告)日:2011-07-13
Cetp Inhibitors
申请人:Ali Amjad
公开号:US20090264405A1
公开(公告)日:2009-10-22
Compounds of Formula I, including pharmaceutically acceptable salts of the compounds, are CETP inhibitors, and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis.